Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Contemporary Oncology (Poznan, Poland)|April 10, 2018
Immunotherapy of melanomaIwona Lugowska, Pawel Teterycz, Piotr RutkowskiWorld Journal of Surgical Oncology|July 27, 2019
Comparison of seventh and eighth edition of AJCC staging system in melanomas at locoregional stagePawel Teterycz, Iwona Ługowska, Hanna Koseła-Paterczyk, et al.Scientific Reports|February 12, 2025
Systemic inflammation index is a predictive and prognostic factor in patients with liposarcoma or leiomyosarcoma treated with trabectedinPawel Sobczuk, Paulina Filipowicz, Lukasz Lamparski, et al.Journal of Cancer|March 28, 2018
IDH1/2 Mutations Predict Shorter Survival in ChondrosarcomaIwona Lugowska, Pawel Teterycz, Michal Mikula, et al.Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|May 23, 2017
[The long-term treatment outcomes of adult osteosarcoma]Iwowa Ługowska, Andrzej Pieńkowski, Anna Szumera-Ciećkiewicz, et al.European Journal of Cancer (Oxford, England : 1990)|June 11, 2025
Avelumab plus axitinib in patients with advanced gastrointestinal stromal tumorPiotr Lukasz Rutkowski, Anna Klimczak, Pawel Teterycz, et al.Cancer Reports (Hoboken, N.J.)|June 11, 2026
Systemic Treatment of Advanced Chordoma With Molecular Targeted Therapies: A Large Multicentre European Retrospective Case SeriesAstrid Lipplaa, Nadia Hindi, Pawel Teterycz, et al.Cancers|October 29, 2020
Multimodal Treatment of Advanced Mucosal Melanoma in the Era of Modern ImmunotherapyPawel Teterycz, Anna M Czarnecka, Alice Indini, et al.Journal for Immunotherapy of Cancer|November 18, 2020
Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: a multicenter international retrospective studyPiotr Rutkowski, Alice Indini, Matilde De Luca, et al.Cancers|November 9, 2024
Adjuvant Use of Pembrolizumab for Stage III Melanoma in a Real-World Setting in EuropeMichael Weichenthal, Joanna Mangana, Iva Gavrilova, et al.Pageof 2